1Charles BA,Shriner D,Doumatey A. A genome-wide association study of serum uric acid in African Americans[J].BMC Med Genomics,2011.17.doi:10.1186/1755-8794-4-17.
4Hollis-Moffatt JE,Gow PJ,Harrison AA. The SLC2A9 nonsynonymous Arg265His variant and gout:evidence for a population-specific effect on severity[J].Arthritis Research & Therapy,2011.R85.doi:10.1186/ar3356.
5Wang B,Meng D,Wang J. Genetic association of polymorphism rs1333049 with gout[J].Rheumatology(Oxford),2011.1559-1561.
6Sigi-Itou S,Goto Y,Suzuki K. Significant association between methylenetetrahydrofolate reductase 677T allele and hyperuricemia among adult Japanese subjects[J].Nutrition Research,2009.710-715.
8McCormack WJ,Parker AE,O'Neill LA. Toll-like receptors and NOD-like receptors in rheumatic diseases[J].Arthritis Research & Therapy,2009.243.doi:10.1186/ar2729.
9Joosten LA,Netea MG,Mylona E. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis[J].Arthritis and Rheumatism,2010.3237-3248.
10Amaral FA,Costa VV,Tavares LD. NLRP3 inflammasome-mediated neutrophil recruitment and bypernociception depend on leukotriene B (4) in a murine model of gout[J].Arthritis and Rheumatism,2012.474-484.doi:10.1002/art.33355.
二级参考文献45
1Nan H,Qiao Q,Dong Y,et al.The prevalence of hyperuricemia in a population of the coastal city of Qingdao,China.J Rheuma-tol,2006,33:1346-1350.
2Lippi C,Montagnana M,Franchini M,et al.The paradoxical re-lationship between serum uric acid and cardiovascular disease.Clin Chim Acta,2008,392:1-7.
3Strasak AM,Kelleher CC,Brant LJ,et al.Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28 613 elderly women:a prospective 21-year follow-up study.Int J Cardiol,2008,125:232-239.
5Enomoto A,Kimura H,Chairoungdua A,et al.Molecular dentifi-cation of a renal urate union exchanger that regulates blood urate levels.Nature,2002,417:447-452.
6Hediger MA,Johnson RJ,Miyazaki H,et al.Molecular physiolo-gy of urate transport.Physiology (Bethesda),2005,20:125-133.
7Iwai N,Mino Y,Hosoyamada M,et al.A high prevalenceof renal hypouricemia caused by inactive SLC22A12 in Japanese.Kidney Int,2004,66:935-944.
8Fang J,Alderman MH.Serum uric acid and cardiovascular mor-tality:the NHANES I epidemiologic follow-up study,1971 1992.National Health and Nutrition Examination Survey.JAMA,2000,283:2404-2410.
9Ichida K,Hosoyamada M,Hisayome I,et al.Clinical and mole-cular analysis of patients with renal hypouricemia in Japan:influ-ence of URAT1 gene on urinary urate excretion.J Am Soc Nep-hrol,2004,15:164-173.
10Tanaka M,Itoh K,Matsushita K,et al.Two malsiblings with hereditary renal hypouricemia and exercise-induced ARF.Am J Kidney Dis,2003,42:1287-1292.
8Donn R, Alourfi Z, de Benedetti F. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum, 2002, 46: 2402-2409.
9Lee YH, Bae SC, Song GG. The association between the func- tional PTPN22 1858 C/T and MIF -173C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis. Inflam Res, 2012, 61: 411-415.
10Przybylowska K, Mrowicki J, Sygut A. Contribution of the -173G/ C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases. Pol Przegl Chir, 2011, 83 : 76-80.
